Professional Endeavors
Dr. Rincón Zuno’s medical career is distinguished by his roles in clinical practice, epidemiological leadership, and hospital administration. Since 2007, he has practiced as a Pediatric Infectologist at the Centro Médico de Toluca, where he also serves as Head of the Epidemiology Department. Additionally, he is the Chief of Infectology Services at the Hospital para el Niño IMIEM, a role he has held since 2013. Notably, he served as the Medical Director of the same hospital from 2018 to 2019. His professional responsibilities are multifaceted, combining patient care, hospital management, and disease surveillance.
Contributions and Research Focus On mycology
Dr. Rincón Zuno has significantly contributed to research in pediatric infectious diseases, focusing particularly on antimicrobial resistance and epidemiological patterns in Mexico. His involvement in major national research networks like SIREVA and INVIFAR has led to critical publications in journals such as PLoS One, Microbial Drug Resistance, International Journal of Infectious Diseases, and Medical Mycology. His work examines changing serotypes of Streptococcus pneumoniae, trends in drug resistance, and the microbiological impact of the COVID-19 pandemic, making him a valuable voice in infectious disease control in Latin America.
Impact and Influence
Through his scholarly activities and public health initiatives, Dr. Rincón Zuno has made a lasting impact on pediatric and infectious disease practices in Mexico. He is a clinical leader in the COEFAR program in the State of Mexico and a mentor to numerous postgraduate theses. As President of Infectology and Pediatrics Academies at UNAM Campus Siglo XXI, his influence extends into academic policy, curriculum development, and professional training. His commitment to educational excellence and health system strengthening exemplifies his broader social and scientific impact.
Research Skills
Dr. Rincón Zuno is recognized for his expertise in clinical epidemiology, antimicrobial resistance surveillance, hospital infection control, and pediatric infectious diseases. He is proficient in data interpretation from multicenter surveillance networks, scientific writing, and collaborative research coordination. His active participation in research collaborations with top institutions has showcased his ability to bridge clinical insights with public health implications, positioning him as a respected scholar and clinician.
Awards and Honors
Dr. Rincón Zuno has been honored through multiple leadership roles, including being President and Founding Member of the Mexiquense College of Infectology and Clinical Microbiology A.C. He is a certified member of the Mexican Councils of Pediatrics and Infectology, and has served in leadership positions within national infectious disease associations. He is also a titular member of the Mexiquense Academy of Medicine and the American Society of Infectious Diseases, highlighting both national and international recognition.
Academic Cites and Publications
Dr. Rincón Zuno’s work has been widely cited, with several key articles influencing the understanding of antimicrobial trends in Latin America. His publications cover areas such as carbapenem resistance, invasive bacterial infections, and fungal diseases like fusariosis, showing a broad range of research involvement. Notable journals that have featured his work include PeerJ, Revista Médica del IMSS, and Pathogens. His consistent contribution to peer-reviewed literature supports his reputation as a leading voice in pediatric infectious disease research.
Legacy and Future Contributions
With over two decades of dedicated service in medicine, Dr. Rincón Zuno is shaping a legacy defined by scientific excellence, clinical leadership, and educational mentorship. His future contributions are likely to focus on enhancing pediatric infection control, advancing resistance surveillance programs, and training the next generation of clinical scientists. As a mentor, researcher, and health leader, he is poised to continue influencing national health policy and global research collaborations.
Publications Top Notes
Changing trends in S. pneumoniae serotypes in unvaccinated populations in Mexico (2000–2014)
Journal: International Journal of Infectious Diseases
Date: May 2017; Volume 58, Pages 1–7
Authors: Carnalla-Barajas MN, Soto-Noguerón A, Sánchez-Alemán MA, Solórzano-Santos F, Velazquez-Meza ME, Echániz-Aviles G; Grupo SIREVA-México
DOI: 10.1016/j.ijid.2017.02.005
Panorama of antimicrobial resistance in Mexico from 47 centers across 20 states over six months
Journal: PLoS ONE
Date: March 26, 2019; Volume 14(3): e0209865
Authors: Garza-González E, Morfín-Otero R, Mendoza-Olazarán S, Bocanegra-Ibarias P, Flores-Treviño S, Rodríguez-Noriega E, Ponce-de-León A, Rincón-Zuno J, and others
DOI: 10.1371/journal.pone.0209865
Evolution of antimicrobial resistance in Mexico over the past decade – INVIFAR group findings
Journal: Microbial Drug Resistance
Date: November 2020; Volume 26(11), Pages 1372–1382
Authors: Garza-González E, Franco-Cendejas R, Morfín-Otero R, Echaniz-Aviles G, Rojas-Larios F, Rincón-Zuno J, and others
DOI: 10.1089/mdr.2019.0354
Rise of antimicrobial resistance during COVID-19 pandemic – INVIFAR network data
Journal: Microbial Drug Resistance
Date: March 2022; Volume 28(3), Pages 338–345
Authors: López-Jácome LE, Fernández-Rodríguez D, Franco-Cendejas R, Camacho-Ortiz A, Rodríguez-Noriega E, Rincón-Zuno J, and others
DOI: 10.1089/mdr.2021.0231
Current status of antimicrobial resistance in pediatric population at a Mexican hospital
Journal: Revista Médica del Instituto Mexicano del Seguro Social
Date: 2022; Volume 60(4), Pages 371–378
Authors: Sánchez-Álvarez BP, Rincón-Zuno J, Mejía-Caballero L, Hernández-Castellanos CA, Diaz-Conde M, Magaña-Matienzo I, Terrazas-Peraza AA
Bacterial incidence and drug resistance in blood, CSF, and pleural samples (2019–2020)
Journal: PeerJ
Date: January 17, 2023; Volume 11: e14411
Authors: Garza-González E, Camacho-Ortiz A, Ponce-de-Leon A, Ortiz-Brizuela E, Rincón-Zuno J, and others
DOI: 10.7717/peerj.14411
Active antimicrobial resistance surveillance and carbapenemase gene distribution by care sites and age groups in Mexico
Journal: Pathogens
Date: September 7, 2023; Volume 12(9)
Authors: Rojas-Larios F, Martínez-Guerra BA, López-Jácome LE, Bolado-Martínez E, Rincón-Zuno J, and others
DOI: 10.3390/pathogens12091144